Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells. - Wikidata - wikimedia - TriplyDB

Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells.

Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells.

http://www.wikidata.org/entity/Q34748489

about

Synthetic biology approaches to engineer T cells Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection.Bispecific Antibodies as a Development Platform for New Concepts and Treatment Strategies.Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells.Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme.Harnessing the immune system in the battle against breast cancer.

P2860

Q26798366-B6D1F3B0-230B-4E07-A96D-772CE78A615A Q34517676-BFC3CDB4-028F-4E21-BA52-FC52FC792BC5 Q34548319-072C98F3-9274-4913-9025-575399B0F487 Q36131489-0B8A32EA-1087-4D78-9437-88E58341DF84 Q38878322-8B72BACF-6971-4757-ACFF-56F2D59B90DB Q49884762-8EB8D837-74AC-45A1-AFB9-5B72818CFDFC

P2860

Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells.

http://www.wikidata.org/entity/Q34748489

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Targeted cancer immunotherapy ...... novel gene-engineered T cells.

@ast

Targeted cancer immunotherapy ...... novel gene-engineered T cells.

@en

Targeted cancer immunotherapy ...... novel gene-engineered T cells.

@nl

type

label

Targeted cancer immunotherapy ...... novel gene-engineered T cells.

@ast

Targeted cancer immunotherapy ...... novel gene-engineered T cells.

@en

Targeted cancer immunotherapy ...... novel gene-engineered T cells.

@nl

prefLabel

Targeted cancer immunotherapy ...... novel gene-engineered T cells.

@ast

Targeted cancer immunotherapy ...... novel gene-engineered T cells.

@en

Targeted cancer immunotherapy ...... novel gene-engineered T cells.

@nl

P1433

Q34748489-91AE4335-9587-45B9-B078-D7068E644804

P1476

Q34748489-5FBC90A9-0428-4881-9DDE-6490E9DECD99

P2093

Q34748489-049C650F-166D-47B9-93C0-AF02D732DC69

Q34748489-196750A6-5991-4D11-B755-78E2D7052582

Q34748489-3C1A0C29-3209-495D-A37C-BBCD4853EEB4

Q34748489-978D077F-86DF-418A-A908-233941FD398F

Q34748489-9CB7AB8A-EC39-4653-8602-F57882979ED5

Q34748489-B643B480-07BD-492A-B334-0034123BBF3C

P2860

Q34748489-03F4E784-7692-47C0-A085-52156FFC8016

Q34748489-0451769D-C88E-42CB-B377-8AAA81D679D3

Q34748489-09636B92-3943-4BED-AF61-05A48AD31856

Q34748489-09AFF0C0-59E5-4340-8BA8-3EE4D8068136

Q34748489-0AF70DEA-6C39-4EB0-9A0A-3004E32F05ED

Q34748489-0FF773F5-436F-4BE2-8859-3398C44B119A

Q34748489-1014600A-D03E-4933-8FFC-9FB63DCE860D

Q34748489-18079313-B61E-4199-815C-306734490C6F

Q34748489-19225880-EB91-481C-B912-0563C1E9A07D

Q34748489-220C6AB6-C0A5-4AD3-BB5B-DC7D79F1328B

P2888

Q34748489-C1260C42-FE2C-4ED6-8EC4-53D62FD7FEC0

P304

Q34748489-3B0AA4FB-A811-4A6A-8096-5176987A4C09

P31

Q34748489-A43701A8-CE32-4661-9DB7-DCD0D0D68000

P356

Q34748489-12C4B10E-EAC8-414E-BF99-C651170A7F98

P478

Q34748489-576385BD-9037-46D7-A4FC-BFF96F646912

P577

Q34748489-0EE510BC-0C55-446D-A015-8C462BD6EB30

P5875

Q34748489-01E041D7-2CBB-43DE-8EB0-B4E0EFE2FF90

P6179

Q34748489-1D25E2FC-F386-4CE9-9B9C-BFAAEF8A8F3A

P698

Q34748489-D6F96AC4-992A-42BB-99CA-ADB406477B29

P921

Q34748489-71D100DA-BFA0-44CE-92BA-C78CDCE94558

Q34748489-7AA031CD-D93C-4519-A545-1A8675263D5E

P932

Q34748489-7FBBB27D-DA3A-4689-BA03-AAF66B7817A4

P356

S12967-014-0347-2

P1433

Journal of Translational Medicine

P1476

Targeted cancer immunotherapy ...... novel gene-engineered T cells.

@en

P2093

Archana Thakur

http://www.w3.org/2001/XMLSchema#string

Caitlin Stashwick

http://www.w3.org/2001/XMLSchema#string

Daniel J Powell

http://www.w3.org/2001/XMLSchema#string

Katarzyna Urbanska

http://www.w3.org/2001/XMLSchema#string

Lawrence G Lum

http://www.w3.org/2001/XMLSchema#string

Rachel C Lynn

http://www.w3.org/2001/XMLSchema#string

P2860

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

Bispecific T-cell engaging antibodies for cancer therapy

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

Bispecific antibodies in cancer therapy.

A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptor.

In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB)

P2888

s12967-014-0347-2

P304

347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-014-0347-2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269712417

http://www.w3.org/2001/XMLSchema#string

P6179

1035082601

http://www.w3.org/2001/XMLSchema#string

P698

25496493

http://www.w3.org/2001/XMLSchema#string

P921

P932

4272781

http://www.w3.org/2001/XMLSchema#string